Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 448

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2

Sacher, Frédéric, Probst, Vincent, Maury, Philippe, Babuty, Dominique, Mansourati, Jacques, Komatsu, Yuki, Marquie, Christelle, Rosa, Antonio, Diallo, Abou, Cassagneau, Romain, Loizeau, Claire, Martins, Raphael, Field, Michael E., Derval, Nicolas, Miyazaki, Shinsuke, Denis, Arnaud, Nogami, Akihiko, Ritter, Philippe, Gourraud, Jean-Baptiste, Ploux, Sylvain, Rollin, Anne, Zemmoura, Adlane, Lamaison, Dominique, Bordachar, Pierre, Pierre, Bertrand, Jaïs, Pierre, Pasquié, Jean-Luc, Hocini, Mélèze, Legal, François, Defaye, Pascal, Boveda, Serge, Iesaka, Yoshito, Mabo, Philippe, Haïssaguerre, Michel·2013·Circulation

Abstract

Background—: Implantable cardioverter-defibrillator indications in Brugada syndrome remain controversial, especially in asymptomatic patients. Previous outcome data are limited by relatively small numbers of patients or short follow-up durations. We report the outcome of patients with Brugada syndrome implanted with an implantable cardioverter-defibrillator in a large multicenter registry. Methods and Results—: A total of 378 patients (310 male; age, 46±13 years) with a type 1 Brugada ECG pattern implanted with an implantable cardioverter-defibrillator (31 for aborted sudden cardiac arrest, 181 for syncope, and 166 asymptomatic) were included. Fifteen patients (4%) were lost to follow-up. During a mean follow-up of 77±42 months, 7 patients (2%) died (1 as a result of an inappropriate shock), and 46 patients (12%) had appropriate device therapy (5±5 shocks per patient). Appropriate device therapy rates at 10 years were 48% for patients whose implantable cardioverter-defibrillator indication was aborted sudden cardiac arrest, 19% for those whose indication was syncope, and 12% for the patients who were asymptomatic at implantation. At 10 years, rates of inappropriate shock and lead failure were 37% and 29%, respectively. Inappropriate shock occurred in 91 patients (24%; 4±4 shocks per patient) because of lead failure (n=38), supraventricular tachycardia (n=20), T-wave oversensing (n=14), or sinus tachycardia (n=12). Importantly, introduction of remote monitoring, programming a high single ventricular fibrillation zone (>210–220 bpm), and a long detection time were associated with a reduced risk of inappropriate shock. Conclusions—: Appropriate therapies are more prevalent in symptomatic Brugada syndrome patients but are not insignificant in asymptomatic patients (1%/y). Optimal implantable cardioverter-defibrillator programming and follow-up dramatically reduce inappropriate shock. However, lead failure remains a major problem in this population.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.001941

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 448

Metadata

Authors
Sacher, F., Probst, V., Maury, P., Babuty, D., Mansourati, J., Komatsu, Y., Marquie, C., Rosa, A., Diallo, A., Cassagneau, R., Loizeau, C., Martins, R., Field, M. E., Derval, N., Miyazaki, S., Denis, A., Nogami, A., Ritter, P., Gourraud, J.-B., Ploux, S., Rollin, A., Zemmoura, A., Lamaison, D., Bordachar, P., Pierre, B., Jaïs, P., Pasquié, J.-L., Hocini, M., Legal, F., Defaye, P., Boveda, S., Iesaka, Y., Mabo, P., & Haïssaguerre, M.
Venue
Circulation
Published
2013-10-15
Volume
128
Issue
16
Pages
1739-1747
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2101633048
Cited by
448
References
41
FWCI
26.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2. https://app.cochat.ai/papers/10.1161/circulationaha.113.001941
The paper
Sacher, F., Probst, V., Maury, P., Babuty, D., Mansourati, J., Komatsu, Y., Marquie, C., Rosa, A., Diallo, A., Cassagneau, R., Loizeau, C., Martins, R., Field, M. E., Derval, N., Miyazaki, S., Denis, A., Nogami, A., Ritter, P., Gourraud, J.-B., . . . Haïssaguerre, M. (2013). Outcome After Implantation of a Cardioverter-Defibrillator in Patients With Brugada Syndrome: A Multicenter Study–Part 2. Circulation. https://doi.org/10.1161/circulationaha.113.001941

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.